🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Tatyana Feldman

Hackensack University Medical Center

ORCID: 0000-0002-4458-2896

Also affiliated with Hackensack Meridian Health

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial”.

Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial

The Lancet Haematology(2022)10.1016/s2352-3026(22)00318-0
N/A
1.4DataRank · unranked
41 citations

Lu Chen, Yago Nieto, Leona Holmberg, Patrick B. Johnston, Matthew Mei +20 more

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study

Blood Advances(2023)10.1182/bloodadvances.2023010330
N/A
1.0DataRank · unranked
48 citations

Önder Alpdoğan, Robert A. Baiocchi, Jonathan E. Brammer, Tatyana Feldman, Marcelo Capra +15 more

Brentuximab vedotin plus cyclophosphamide, doxorubicin, etoposide, and prednisone followed by brentuximab vedotin consolidation in CD30-positive peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 study

The Lancet Haematology(2024)10.1016/s2352-3026(24)00171-6
N/A
0.673DataRank · unranked
20 citations

Jasmine Zain, Kerry J. Savage, Tatyana Feldman, Jonathan E. Brammer, Lu Chen +14 more

Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up

Blood Cancer Journal(2025)10.1038/s41408-025-01329-2
N/A
0.282DataRank · unranked
5 citations

Barbara Pro, Tim Illidge, Steven M. Horwitz, Lorenz Truemper, Swaminathan P. Iyer +22 more

Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma

Blood Advances(2025)10.1182/bloodadvances.2024015282
N/A
0.185DataRank · unranked
2 citations

Neha Mehta–Shah, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Franck Morschhauser +18 more

Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530]

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.10.011
N/A
0DataRank · unranked
0 citations

Talal El Zarif, Ramya Ramaswami, Amin H. Nassar, Elio Adib, Noha Abdel‐Wahab +25 more

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

UNC Libraries(2025)10.17615/bc35-y591
N/A
0DataRank · unranked
0 citations

Praful Ravi, Robert A. Baiocchi, Noha Abdel‐Wahab, Swetha Kambhampati, Talal El Zarif +25 more

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Leukemia(2021)10.1038/s41375-021-01193-6
N/A
0DataRank · unranked
83 citations

Luca Castagna, Laura Giordano, Vincent T. Ho, Paolo Corradini, Anna Guidetti +61 more

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study

Research Square(2025)10.21203/rs.3.rs-7607922/v1
N/A
0DataRank · unranked
0 citations

Brian L. Egleston, Zachary AK Frosch, Ralphael Steiner, Ariela Noy, Veronica Carvajal +42 more

Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0964
N/A
0DataRank · unranked
13 citations

Tatyana Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey +21 more

Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

(2023)10.1158/1078-0432.c.6532596
N/A
0DataRank · unranked
0 citations

Tatyana Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey +21 more

Data from Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach

(2023)10.1158/1078-0432.c.6532596.v1
N/A
0DataRank · unranked
0 citations

Tatyana Feldman, Jacob D. Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey +21 more

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States

Clinical Lymphoma Myeloma & Leukemia(2024)10.1016/j.clml.2024.03.011
N/A
0DataRank · unranked
15 citations

Talal El Zarif, Ramya Ramaswami, Amin H. Nassar, Elio Adib, Noha Abdel‐Wahab +25 more